TOP HEADLINES

Featured Story

Flowonix raises $40M to support next-generation infusion pump with improved MRI compatibility

Flowonix, maker of the implantable Prometra infusion pump for chronic pain patients, announced that it has raised $40 million in debt and equity financing led by private equity fund Élevage Capital Management.

Catalent buys particle engineering outfit Micron Technologies

Delivery giant Catalent bought out Micron Technologies, a company that specializes in particle size engineering. The acquisition gives Catalent a leg up in early-stage drug development, according to a release, adding to its slate of oral and inhaled technologies.

NSF funds further research into only FDA-cleared catheter for rectal delivery

The National Science Foundation this week awarded a second research grant to the maker of the only FDA-cleared catheter for rectal delivery of medication and liquids to expand the device's use beyond the hospice.

Medical marijuana company licenses RapidMist device for buccal delivery

Medical marijuana company CannScience Innovations entered into a nonbinding agreement to license Generex Biotechnology's RapidMist device for the buccal delivery of its developmental stage medical marijuana products.

Cynapsus releases clinical trial data about its sublingual thin-film strip for Parkinson's

Cynapsus Therapeutics touted the results of its Phase 2 clinical trial of its sublingual thin-film-strip formulation of apomorphine for the management of OFF motor symptoms of Parkinson's disease.

MORE NEWS